Showing results (231-240 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|November 17, 2025
Addressing Non-Exchangeability in Hybrid Control Studies: A Variable Selection ApproachZhiwei Zhang, Jialuo Liu, Peisong HanPharmaceutical Statistics|October 1, 2025
Extending Multiple Testing With Unknown Test Dependency via the CoCo Test: With Applications to Cancer StudiesJiangtao Gou, Kai Wu, Oliver Y ChénPharmaceutical Statistics|August 20, 2016
Effect of design specifications in dose-finding trials for combination therapies in oncologyAkihiro Hirakawa, Hiroyuki Sato, Masahiko GoshoPharmaceutical Statistics|September 26, 2025
Adjustment for Inconsistency in Adaptive Phase 2/3 Designs With Dose OptimizationCong Chen, Mo Huang, Xuekui ZhangPharmaceutical Statistics|August 1, 2025
A Flexible Seamless Phase 2/3 Design With Biomarker-Driven Subgroup Enrichment and Sample Size Re-EstimationZizhong Tian, Liwen Wu, Rachael Liu, et al.Pharmaceutical Statistics|August 27, 2021
Encouragement of subgroup assessment by the FDARobert TemplePharmaceutical Statistics|May 22, 2021
Joint confidence region estimation on predictive valuesBraydon J Schaible, Jingjing YinPharmaceutical Statistics|December 17, 2025
A Tree-Based Scan Statistic for Detecting Signals of Drug-Drug Interactions in Spontaneous Reporting DatabasesSeok-Jae Heo, Inkyung JungPharmaceutical Statistics|December 10, 2025
Optimizing Dosing Strategies in Cell Therapy With Machine Learning and Exposure-Response IntegrationShuqi Wang, Yunqi Zhao, Jia Li, et al.Pharmaceutical Statistics|June 21, 2025
Further Practical Guidance on Adjusting Time-To-Event Outcomes for Treatment SwitchingClaire Watkins, Eva Kleine, Miguel Miranda, et al.Pageof 119